{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:21:41Z","timestamp":1759774901552},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,1,3]],"date-time":"2008-01-03T00:00:00Z","timestamp":1199318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s10549-007-9878-z","type":"journal-article","created":{"date-parts":[[2008,1,2]],"date-time":"2008-01-02T13:58:08Z","timestamp":1199282288000},"page":"569-573","source":"Crossref","is-referenced-by-count":27,"title":["The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation"],"prefix":"10.1007","volume":"112","author":[{"given":"Doo Ho","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Yeon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Hyuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Sook","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sei Hyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Ho","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce G.","family":"Haffty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,3]]},"reference":[{"key":"9878_CR1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM199601183340301","volume":"334","author":"AA Langston","year":"1996","unstructured":"Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA (1996) BRCA1 mutations in a population-based sample of young women with breast cancer. N Eng J Med 334:137\u2013142","journal-title":"N Eng J Med"},{"key":"9878_CR2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jama.279.12.915","volume":"279","author":"B Newman","year":"1998","unstructured":"Newman B, Mu H, Butler LM, Millikan RC, Moorman PG, King MC (1998) Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 279:915\u2013921","journal-title":"JAMA"},{"key":"9878_CR3","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","volume":"91","author":"J Peto","year":"1999","unstructured":"Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evance C, Deacon J, Stratton MR (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943\u2013949","journal-title":"J Natl Cancer Inst"},{"key":"9878_CR4","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1126\/science.282.5395.1893","volume":"282","author":"S Matsuoka","year":"1998","unstructured":"Matsuoka S, Huang M, Elledge SJ (1998) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282:1893\u20131897","journal-title":"Science"},{"key":"9878_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng879","volume":"31","author":"H Meijers-Heijbor","year":"2002","unstructured":"Meijers-Heijbor H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton D, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans DG, Houlston R, Murday V, Norod S, Peretz T, Peto J, Phelan C, Zhang HX, Szabo C, Devilee P, Goldgar D, Futreal PA, Nathanson KL, Weber B, Rahman N, Stratton MR, CHEK2-Breast cancer Consortium (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 and BRCA2 mutations. Nat Genet 31:55\u201359","journal-title":"Nat Genet"},{"key":"9878_CR6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1086\/341943","volume":"71","author":"P Vahteristo","year":"2002","unstructured":"Vahteristo P, Bartkova J, Eerola H, Syrjakoski K, Ojala S, Kilpivaara O, Tamminen A, Kononen J, Aitomaki K, Heikkila P, Holli K, Blomqvist C, Bartek J, Kallioniemi OP, Nevanlinna H (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71:432\u2013438","journal-title":"Am J Hum Genet"},{"key":"9878_CR7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1086\/421251","volume":"74","author":"The CHEK2 Breast Cancer Case-Control Consortium","year":"2004","unstructured":"The CHEK2 Breast Cancer Case-Control Consortium (2004) CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 74:1175\u20131182","journal-title":"Am J Hum Genet"},{"key":"9878_CR8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1200\/JCO.2005.05.5160","volume":"25","author":"M Weischer","year":"2007","unstructured":"Weischer M, Bojesen SE, Tybjoerg-Hansen A, Axelsson CK, Nordestgaard BG (2007) Increased risk of breast cancer associated with CHEK2*1100delC. J Clin Oncol 25:57\u201363","journal-title":"J Clin Oncol"},{"key":"9878_CR9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ijc.11414","volume":"108","author":"A Osorio","year":"2004","unstructured":"Osorio A, Rodriguez-Lopez R, Diez O, de la Hoya M, Martinez JI, Vega A, Esteban-Cardenosa E, Alononso C, Caldes T, Benitez J (2004) The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer. Int J Cancer 108:54\u201356","journal-title":"Int J Cancer"},{"key":"9878_CR10","first-page":"305","volume":"53","author":"E Kwiatkowska","year":"2006","unstructured":"Kwiatkowska E, Skasko E, Niwinska A, Wojciechowska-Lacka A, Rachtan J, Molong L, Nowakowska D, Konopka B, Janice-Jankowska A, Paszko Z, Steffen J (2006) Low frequency of the CHEK2*1100delC mutation among breast cancer probands from three regions of Poland. Neoplasma 53:305\u2013308","journal-title":"Neoplasma"},{"key":"9878_CR11","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/sj.bjc.6602381","volume":"92","author":"CR Jekimovs","year":"2005","unstructured":"Jekimovs CR, Chen X, Arnold J, Gatei M, Richard DJ, kConFab Investigators, Spurdle AB, Khanna KK, Chenevix-Trench G (2005) Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals. Br J Cancer 92:784\u2013790","journal-title":"Br J Cancer"},{"key":"9878_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2350-4-1","volume":"4","author":"K Offit","year":"2003","unstructured":"Offit K, Pierce H, Kirchhoff T, Kolachana P, Rapaport B, Gregersen P, Johnson H, Yossepowitch O, Huang H, Satagopan J, Robson M, Scheuer L, Nafa K, Ellis N (2003) Frequency of CHEK2*1100delC in New York breast cancer cases and controls. BMC Med Genet 4:1","journal-title":"BMC Med Genet"},{"key":"9878_CR13","doi-asserted-by":"crossref","unstructured":"Gonzalez-Hormazabal P, Casro VG, Blanco R, Gomez F, Peralta O, Waugh E, Bravo T, Reyes JM, Jara L (2007) Absence of CHEK2 1100delC mutation in familial breast cancer cases from a South American population. Breast Cancer Res Treat Sep 18 [Epub ahead of print]","DOI":"10.1007\/s10549-007-9743-0"},{"key":"9878_CR14","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.2004.04.179","volume":"22","author":"DH Choi","year":"2004","unstructured":"Choi DH, Lee MH, Bale AE, Carter D, Haffty BG (2004) Incidence of BRCA1 and BRCA2 mutation in young Korean breast cancer patients. J Clin Oncol 22:1638\u20131645","journal-title":"J Clin Oncol"},{"key":"9878_CR15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3346\/jkms.2004.19.2.269","volume":"19","author":"SH Ahn","year":"2004","unstructured":"Ahn SH, Hwang UK, Kwak BS, Kang HJ, Kim JS, Ko BK, Ko CD, Yoon KS, Cho DY Kim JS, Son BH (2004) Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients. J Korean Med Sci 19:269\u2013274","journal-title":"J Korean Med Sci"},{"key":"9878_CR16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2005.12.031","volume":"245","author":"SH Ahn","year":"2007","unstructured":"Ahn SH, Son BH, Yoon KS, Noh DY, Han W, Kim SW, Lee ES, Park HL, Hong YJ, Choi JJ, Moon SY, Kim MJ, Kim KH, Kwak BS, Cho DY (2007) BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations. Cancer Lett 245:90\u201395","journal-title":"Cancer Lett"},{"key":"9878_CR17","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1086\/375121","volume":"72","author":"H Meijers-Heijboer","year":"2003","unstructured":"Meijers-Heijboer H, Wijnen J, Vasen H, Wasielewski M, Wagner A, Hollestelle A, Elstrodt F, van den Bos R, de Snoo A, Fat GT, Brekelmans C, Jagmohan S, Franken P, Verkuijlen P, van den Ouweland A, Chapman P, Tops C, Moslein G, Burn J, Lynch H, Klijn J, Fodde R, Schutte M (2003) The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet 72:1308\u20131314","journal-title":"Am J Hum Genet"},{"key":"9878_CR18","first-page":"8153","volume":"63","author":"RA Oldenburg","year":"2003","unstructured":"Oldenburg RA, Kroeze-Jansema K, Kraan J, Morreau H, Klijn JG, Hoogerbrugge N, Ligtenberg MJ, van Asperen CJ, Vasen HF, Meijers C, Meijers-Heijboer H, de Bock TH, Cornelisse CJ, Devilee P (2003) The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1\/BRCA2 multiple case families. Cancer Res 63:8153\u20138157","journal-title":"Cancer Res"},{"key":"9878_CR19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1200\/JCO.2006.06.3024","volume":"25","author":"MK Schmidt","year":"2007","unstructured":"Schmidt MK, Tollenaar RA, de Kemp SR, Broeks A, Cornelisse CJ, Smit VT, Peterse JL, van Leeuwen PF, van\u2019t Veer LJ (2007) Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC Germline mutation. J Clin Oncol 25:64\u201369","journal-title":"J Clin Oncol"},{"key":"9878_CR20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2407-7-163","volume":"7","author":"S Margolin","year":"2007","unstructured":"Margolin S, Eiberg H, Lindblom A, Bisgaard ML (2007) CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer. BMC Cancer 7:163","journal-title":"BMC Cancer"},{"key":"9878_CR21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10549-004-4023-8","volume":"90","author":"Z Kleibl","year":"2005","unstructured":"Kleibl Z, Novotny J, Bezdickova D, Malik R, Kleiblova P, Forestova L, Petruzelka L, Ilencikova D, Cinek P, Pohlreich P (2005) The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic. Breast Cancer Res Treat 90:165\u2013167","journal-title":"Breast Cancer Res Treat"},{"key":"9878_CR22","doi-asserted-by":"crossref","unstructured":"Gutierrez-Enriquez S, Balmana J, Baiget M, Diez O (2007) Detection of the CHEK2 1100delC mutation by MLPA BRCA1\/2 analysis: a worthwhile strategy for clinical applicability in 1100delC low-frequency populations? Breast Cancer Res Treat Apr 26 [Epub ahead of print]","DOI":"10.1007\/s10549-007-9555-2"},{"key":"9878_CR23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/humu.20051","volume":"24","author":"MA Caligo","year":"2004","unstructured":"Caligo MA, Agata S, Aceto G, Crucianelli R, Manoukian S, Peissel B, Scaini MC, Sensi E, Veschi S, Cama A, Radice P, Viel A, D\u2019Andrea E, Montagna M (2004) The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy. Hum Mutat 24:100\u2013101","journal-title":"Hum Mutat"},{"key":"9878_CR24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ijc.20073","volume":"110","author":"MR Dufault","year":"2004","unstructured":"Dufault MR, Betz B, Wappenschmidt B, Hoffman W, Bandick K, Golla A, Pietschmann A, Nestre-Kramling, Rheim K, Huttner C, von Lindern C, Dall P, Kiechle M, Untch M, Jonat W, Meindl A, Scherneck S, Niederacher D, Schmutzler RK, Arnold N (2004) Limited relevance of the CHEK2 gene in hereditary breast cancer. Int J Cancer 110:320\u2013325","journal-title":"Int J Cancer"},{"key":"9878_CR25","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.ejca.2005.04.049","volume":"41","author":"MU Rashid","year":"2005","unstructured":"Rashid MU, Jakubowska A, Justenhoven C, Harth V, Pesch B, Baisch C, Pierl CB, Bruning T, Ko Y, Benner A (2005) Wichmann HE, Brauch H, Hamann U, German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer. Eur J Cancer 41:2896\u20132903","journal-title":"Eur J Cancer"},{"key":"9878_CR26","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1002\/ijc.23026","volume":"121","author":"DW Bell","year":"2007","unstructured":"Bell DW, Kim SH, Godwin AK, Schiripo TA, Harris PL, Haserlat SM, Wahrer DC, Haiman CA, Daly MB, Niendorf KB, Smith MR, Sgroi DC, Garber JE, Olopade OI, Marchand LL, Henderson BE, Altshuler D, Haber DA, Freedman ML (2007) Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. Int J Cancer 121:2661\u20132667","journal-title":"Int J Cancer"},{"key":"9878_CR27","first-page":"2554","volume":"366","author":"N Johnson","year":"2005","unstructured":"Johnson N, Fletcher O, Naceur-Lombardelli C, dos Santos Silva I, Ashworth A, Peto J (2005) Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study. Lancet 366:2554\u20132557","journal-title":"Lancet"},{"key":"9878_CR28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ijc.11384","volume":"108","author":"K Syrjakoski","year":"2004","unstructured":"Syrjakoski K, Kuukasjarvi T, Auvinen A, Kallioniemi OP (2004) CHEK2 1100delC is not a risk factor for male breast cancer population. Int J Cancer 108:475\u2013476","journal-title":"Int J Cancer"},{"key":"9878_CR29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ijc.11385","volume":"108","author":"S Neuhausen","year":"2004","unstructured":"Neuhausen S, Dunning A, Steele L, Yakumo K, Hoffman M, Szabo C, Tee L, Baines C, Pharoah P, Goldgar D, Easton D (2004) Role of CHEK2*1100delC in unselected series of non-BRCA1\/2 male breast cancers. Int J Cancer 108:477\u2013478","journal-title":"Int J Cancer"},{"key":"9878_CR30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ijc.11603","volume":"108","author":"T Ohayon","year":"2004","unstructured":"Ohayon T, Gal I, Baruch RG, Szabo C, Friedman E (2004) CHEK2*1100delC and male breast cancer risk in Israel. Int J Cancer 108:479\u2013480","journal-title":"Int J Cancer"},{"key":"9878_CR31","doi-asserted-by":"crossref","unstructured":"Falchetti M, Lupi R, Rizzolo P, Ceccarelli K, Zanna I, Calo V, Tommasi S, Masala G, Paradiso A, Gullino A, Giannini G, Russo A, Palli D, Ottini L (2007) BRCA1\/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases. Breast Cancer Res Treat Jul 28 [Epub ahead of print]","DOI":"10.1007\/s10549-007-9689-2"},{"key":"9878_CR32","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/jmg.2004.019737","volume":"41","author":"GH Bock de","year":"2004","unstructured":"de Bock GH, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaart RA, Klijn JG (2004) Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant. J Med Genet 41:731\u2013735","journal-title":"J Med Genet"},{"key":"9878_CR33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.radonc.2006.12.002","volume":"82","author":"A Meyer","year":"2007","unstructured":"Meyer A, Dork T, Sohn C, Karstens JH, Bremer M (2007) Breast cancer in patients carrying a germ-line CHEK2 mutation: outcome after breast conserving surgery and adjuvant radiotherapy. Radiother Oncol 82:349\u2013353","journal-title":"Radiother Oncol"},{"key":"9878_CR34","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/373965","volume":"72","author":"M Schutte","year":"2003","unstructured":"Schutte M, Seal S, Barfoot R, Meijers-Heijboer H, Wasielewski M, Evans DG, Eccles D, Meijers C, Lohman F, Klijn J, van den Ouweland A (2003) The Breast Cancer Linkage Consortium, Futreal PA, Nathanson KL, Weber BL, Easton DF, Stratton M, Rahman N. Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility. Am J Hum Genet 72:1023\u20131028","journal-title":"Am J Hum Genet"},{"key":"9878_CR35","first-page":"809","volume":"12","author":"B Kuschel","year":"2003","unstructured":"Kuschel B, Auranen A, Gregory CS, Day NE, Easton DF, Ponder BA, Dunning AM, Pharoah PD (2003) Common polymorphisms in Checkpoint Kinase 2 are not associated with breast cancer risk. Cancer Epidem Biomar 12:809\u2013812","journal-title":"Cancer Epidem Biomar"},{"key":"9878_CR36","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1158\/0008-5472.CAN-06-1990","volume":"66","author":"N Sodha","year":"2006","unstructured":"Sodha N, Mantoni TS, Tavtigian SV, Eeles R, Garret MD (2006) Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activation. Cancer Res 66:8966\u20138970","journal-title":"Cancer Res"},{"key":"9878_CR37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ijc.20299","volume":"111","author":"O Kilpivaara","year":"2004","unstructured":"Kilpivaara O, Vahteristo P, Falck J, Syrjakoski K, Earola H, Easton D, Bartkova J, Lukas J, Heikkila P, Aittomaki K, Holli K, Blomqvist C, Kallionniemi OP, Bartek J, Nevanlinna H (2004) CHEK2 variant I157T may be associated with increased breast cancer risk. Int J Cancer 111:543\u2013547","journal-title":"Int J Cancer"},{"key":"9878_CR38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ijc.21022","volume":"116","author":"N Bogdanova","year":"2005","unstructured":"Bogdanova N, Enssen-Dubrowinskaja N, Feshchenko S, Lazjuk GI, Rogov YI, Dammann O, Bremer M, Karstens JH, Sohn C, Dork T (2005) Association of two mutations in the CHEK2 gene with breast cancer. Int J Cancer 116:263\u2013266","journal-title":"Int J Cancer"},{"key":"9878_CR39","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1158\/1078-0432.CCR-06-0158","volume":"12","author":"C Cybulski","year":"2006","unstructured":"Cybulski C, Gorski B, Huzarski T, Byrski T, Gronwald J, Debniak T, Wokolorczyk D, Jakubowska A, Kowalska E, Oszurek O, Narod SA, Lubinski J (2006) CHEK2-positive breast cancers in young Polish women. Clin Cancer Res 12:4832\u20134835","journal-title":"Clin Cancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-007-9878-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-007-9878-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-007-9878-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:28:57Z","timestamp":1559233737000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-007-9878-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["9878"],"URL":"https:\/\/doi.org\/10.1007\/s10549-007-9878-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,3]]}}}